{
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "document": "Zimmerman_et_al.__2023_",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": true,
    "additional_count": 1
  },
  "completeness_stats": {
    "existing_evidence": 3,
    "new_evidence_found": 1,
    "total_evidence": 4
  },
  "combined_evidence": [
    {
      "id": 1,
      "quote": "Two large studies have explored rVE of recombinant quadrivalent influenza vaccine (RIV4). The Medicare beneficiaries study [10] using retrospective data as described above, reported significant rVE of RIV4 vs. SD-IIV4) against influenza related hospital encounters. Secondly, a randomized controlled trial (RCT) found significant rVE of RIV4 compared with SD-IIV4 among adults 50 years old, but not for adults 65 years old [11].",
      "relevance_explanation": "This quote explicitly states that a randomized controlled trial (RCT) compared the recombinant quadrivalent influenza vaccine (RIV4, which is Flublok) with the standard dose quadrivalent influenza vaccine (SD-IIV4, which includes Fluarix), directly supporting the claim that Flublok (quadrivalent) was evaluated in a pivotal trial against Fluarix (quadrivalent standard-dose vaccine)."
    },
    {
      "id": 2,
      "quote": "Secondly, a randomized controlled trial (RCT) found significant rVE of RIV4 compared with SD-IIV4 among adults 50 years old, but not for adults 65 years old [11].",
      "relevance_explanation": "This quote further clarifies that the pivotal trial was a randomized controlled trial directly comparing RIV4 (Flublok) and SD-IIV4 (which includes Fluarix), confirming the head-to-head evaluation required by the claim."
    },
    {
      "id": 3,
      "quote": "SD-IIV4 included Afluria, Fluarix, FluLaval, Standard Dose Fluzone and FlucelVax. HD-IIV4 was High Dose Fluzone, RIV4 was Flublok and Adj-IV was FluAd.",
      "relevance_explanation": "This quote defines the vaccine types used in the study, confirming that Flublok (RIV4) and Fluarix (SD-IIV4) were among the vaccines compared, directly supporting the claim that Flublok was evaluated against Fluarix (quadrivalent standard-dose vaccine)."
    },
    {
      "id": "comp_1",
      "quote": "c RIV4: Flublok. c SD-IIV4: Afluria, Fluarix, FluLaval, Standard Dose Flu zone and FlucelVax.",
      "relevance_explanation": "This quote explicitly identifies Flublok as RIV4 and Fluarix as one of the SD-IIV4 comparators, confirming that Flublok (quadrivalent) was evaluated against Fluarix (quadrivalent standard-dose vaccine) in the study.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ],
  "completeness_assessment": {
    "missing_aspects": []
  },
  "model_used": "gpt-4.1"
}